Retractable Technologies RVP
NYSE RVP
$0.71 -0.01 (-0.78%)
As of: Sep 10, 2026 · 12:06 PM EDT

Retractable Technologies (RVP) Capital Expenditures (2010 - 2026)

Retractable Technologies' (RVP) quarterly Capital Expenditures came in at $29823.0 in Q2 2026, down 91.02% on a YoY basis from $332250.0 in Q2 2025, and up 378.93% quarter-over-quarter from $6227.0 in Q1 2026.

Analysis

Retractable Technologies (RVP) Capital Expenditures (2010 - 2026) Analysis & Trends

Retractable Technologies (RVP) has reported Capital Expenditures for 17 consecutive years, with $29823.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Capital Expenditures fell 91.02% year-over-year to $29823.0; the trailing twelve-month figure through Jun 2026 stood at $152410.0 (down 89.91% YoY), and the FY2025 full-year result was $535644.0, down 62.8% from the prior year.
  • Capital Expenditures improved to $29823.0 in Q2 2026 per RVP's latest filing, from $6227.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $5.6 million in Q2 2022 and bottomed at $6227.0 in Q1 2026.
  • Historically, Capital Expenditures has averaged $1.1 million across 5 years, with a median of $190046.0 in 2023.
  • The sharpest annual moves came in 2023 and 2024: Capital Expenditures tumbled 98.41% in 2023, then jumped 455.49% in 2024.
  • Over 5 years, Capital Expenditures stood at $2.9 million in 2022, then slumped by 94.79% to $153696.0 in 2023, then jumped by 93.93% to $298058.0 in 2024, then sank by 91.08% to $26572.0 in 2025, then climbed by 12.23% to $29823.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $29823.0, $6227.0, and $26572.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Becton Dickinson 48.41 Bn 47.55 Bn 2.32 Bn 143.00 Mn
2 Medline 27.78 Bn 25.10 Bn 2.22 Bn 111.00 Mn
3 West Pharmaceutical Services 24.42 Bn 23.98 Bn 329.20 Mn 43.20 Mn
4 Baxter International 12.49 Bn 10.34 Bn 1.03 Bn 116.00 Mn
5 Stevanato Group S.p.A 5.70 Bn 5.59 Bn 100.91 Mn -67.01 Mn
6 Acme United 235.29 Mn 230.25 Mn 26.69 Mn 1.07 Mn
7 Rockwell Medical 31.39 Mn 6.60 Mn 3.24 Mn 617,000.00
8 Retractable Technologies 21.15 Mn -18.72 Mn 190,852.00 29,823.00
9 United Health Products 8.85 Mn 8.82 Mn - -
10 Cuprina Holdings (Cayman) 7.88 Mn 4.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29,823.00
Mar 31, 2026 6,227.00
Dec 31, 2025 26,572.00
Sep 30, 2025 89,788.00
Jun 30, 2025 332,250.00
Mar 31, 2025 87,034.00
Dec 31, 2024 298,058.00
Sep 30, 2024 793,785.00
Jun 30, 2024 121,704.00
Mar 31, 2024 226,396.00
Dec 31, 2023 153,696.00
Sep 30, 2023 142,898.00
Jun 30, 2023 88,855.00
Mar 31, 2023 467,530.00
Dec 31, 2022 2.95 Mn
Sep 30, 2022 3.34 Mn
Jun 30, 2022 5.57 Mn
Mar 31, 2022 4.97 Mn
Dec 31, 2021 11.85 Mn
Sep 30, 2021 8.36 Mn